Company
Actithera
- Biotech
- Founded:
- 2021
- Headquarters:
- Street
Description
Actithera develops targeted radioligand therapies by linking radioactive isotopes to designed molecules for delivery of radiation to tumors, producing radiotherapeutics for oncology patients and clinical development.
Related
BetaGlue TherapeuticsBetaGlue Therapeutics develops a localized radiotherapeutic platform delivering precise intratumoral radiation for durable local control;…
RS Research Inc.Develops polymer-drug conjugate delivery platforms for targeted chemotherapy and theranostics, used to improve therapeutic index for…
Iovance Biotherapeutics ($IOVA)Iovance Biotherapeutics develops and manufactures tumor-infiltrating lymphocyte (TIL) cell therapies for treating solid tumors, running…
ElektaElekta builds precision radiation medicine systems and software for radiation therapy, stereotactic radiosurgery, brachytherapy and…
Intelligent TherapeuticsIntelligent Therapeutics engineers novel antibodies and antibody-like molecules for treating solid tumors and rare autoimmune diseases,…
Boundless Bio ($BOLD)Boundless Bio develops clinical-stage precision oncology therapies targeting extrachromosomal DNA mechanisms for patients with…
Sangamo Therapeutics ($SGMO)Sangamo Therapeutics develops genomic medicines using zinc finger, delivery, and integrase platforms for patients with severe diseases…
Vivere OncotherapiesVivere Oncotherapies develops bioengineered cancer immunotherapies designed to help patients’ immune systems target cold tumors and support…
Catalent IndianapolisCatalent Indianapolis provides contract development, manufacturing, and supply services for pharma, biotech, self-care, and wellness…
Tessera TherapeuticsTessera Therapeutics develops Gene Writing technology and non-viral delivery methods to make targeted genome alterations for therapies…
Neumora TherapeuticsNeumora Therapeutics develops precision neuroscience medicines by combining drug discovery, data science, and clinical development to…
Pathos AIPathos AI develops an AI-enabled drug development engine for precision oncology, using multimodal patient data and biological models to…